Tag Archives: 7.1.1

CRASH-3 Discussion

Thank you to Dr. Ben Porter for this summary: The CRASH-3 trial was published in October 2019 and along with collaboration from Prof. Toni Belli (co-investigator on the CRASH-3 trial) we discussed its relevance and applicability to Sydney HEMS operations … Continue reading

Posted in General PH&RM | Tagged , | Leave a comment